4.6 Article

Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 106, Issue 1, Pages 245-253

Publisher

WILEY
DOI: 10.1002/cpt.1375

Keywords

-

Funding

  1. International Serious Adverse Events Consortium
  2. Abbott
  3. Amgen
  4. Daiichi-Sankyo
  5. GlaxoSmithKline
  6. Merck
  7. Novartis
  8. Pfizer
  9. Roche
  10. Sanofi-Aventis
  11. Takeda
  12. Wellcome Trust
  13. Biotechnology and Biological Sciences Research Council-Industrial CASE studentship
  14. AstraZeneca (PI AKD)
  15. National Institute for Health Research (NIHR) Nottingham Digestive Diseases Biomedical Research Unit at the Nottingham University Hospitals NHS Trust and University of Nottingham
  16. EC 5th Framework program [QLRI-CT-2002-02757]
  17. Spanish Medicine Agency, Fondo Europeo de Desarrollo Regional - FEDER [P10-CTS-6470, FIS PI12/00378, PI16/01748]
  18. Instituto de Salud Carlos III
  19. Swedish Medical Products Agency
  20. Swedish Society of Medicine [2008-21619]
  21. Swedish Research Council [Medicine 521-2011-2440, 521-2014-3370, 2017-00641]
  22. Swedish Heart and Lung Foundation [20120557]
  23. NIHR Biomedical Research Centre at Guy's and St. Thomas' NHS Foundation Trust and King's College London
  24. MRC [MR/N005953/1, MR/L006758/1] Funding Source: UKRI

Ask authors/readers for more resources

Some patients prescribed flucloxacillin (similar to 0.01%) develop drug-induced liver injury (DILI). HLA-B*57:01 is an established genetic risk factor for flucloxacillin DILI. To consolidate this finding, identify additional genetic factors, and assess relevance of risk factors for flucloxacillin DILI in relation to DILI due to other penicillins, we performed a genomewide association study involving 197 flucloxacillin DILI cases and 6,835 controls. We imputed single-nucleotide polymorphism and human leukocyte antigen (HLA) genotypes. HLA-B*57:01 was the major risk factor (allelic odds ratio (OR) = 36.62; P = 2.67 x 10(-97)). HLA-B*57:03 also showed an association (OR = 79.21; P = 1.2 x 10(-6)). Within the HLA-B protein sequence, imputation showed valine(97), common to HLA-B*57:01 and HLA-B*57:03, had the largest effect (OR = 38.1; P = 9.7 x 10(-97)). We found no HLA-B*57 association with DILI due to other isoxazolyl penicillins (n = 6) or amoxicillin (n = 15) and no significant non-HLA signals for any penicillin-related DILI.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available